Eli Lilly invests $7.8 billion to acquire Centessa Pharmaceuticals
Eli Lilly has announced an agreement to pay up to <strong>$7.8 billion</strong> to acquire <strong>Centessa Pharmaceuticals</strong>, a company focused on developing new drugs for sleep disorders. This acquisition aims to enhance Lilly's portfolio in the neurology sector.